Clal Biotechnology reported ILS3.75M in Trade Debtors for its fiscal quarter ending in December of 2022.





Trade Debtors Change Date
aTyr Pharma USD 1.04M 544K Sep/2025
Brainstorm Cell Therapeutics USD 67K 4K Mar/2025
Cara Therapeutics USD 2.24M 2.26M Mar/2025
Clal Biotechnology ILS 3.75M 186K Dec/2022
Compugen USD 2.83M 930K Sep/2025
Immunic USD 1.5M 50K Jun/2024
RedHill Biopharma USD 5.35M 1.78M Jun/2025
TherapeuticsMD USD 2.91M 310K Jun/2024